Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
tenacio is a private digital health company focused on cardiovascular care, operating through tenac.io GmbH in Germany and tenac.io, Inc. in the United States. Its core product, OptiCor, is an AI-driven clinical decision support platform that provides individualized cardiovascular risk assessment and treatment recommendations based on clinical data and guideline-based precision medicine. The company initially focused on atrial fibrillation and has described expansion into additional cardiovascular indications including heart failure, coronary artery disease, and broader cardiovascular-kidney-metabolic conditions. tenacio markets its solution to healthcare systems and other healthcare stakeholders as a tool to improve outcomes and reduce costs in cardiovascular disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on tenacio.